CBER’s Goodman Eyes Tissue, Blood Test Innovation Through Post-9/11 Lens
This article was originally published in The Gray Sheet
Executive Summary
Development of tests to screen blood and tissues for multiple pathogens would help safeguard public health and national security, Center for Biologics Evaluation & Research Director Jesse Goodman, MD/MPH, stresses in an Aug. 19 New England Journal of Medicine editorial